Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription Articles published in Eur J Cardiothorac Surg Retrieve available abstracts of 95 articles: HTML format Text format

Single Articles

April 2018
1. VERONESI G, Park B, Cerfolio R, Dylewski M, et al
   Robotic resection of Stage III lung cancer: an international retrospective study.
   Eur J Cardiothorac Surg. 2018 Apr 30. pii: 4990523. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   March 2018
2. PAN X, Gu C, Yang J, Shi J, et al
   Robotic double-sleeve resection of lung cancer: technical aspects.
   Eur J Cardiothorac Surg. 2018 Mar 20. pii: 4944680. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
3. DZIEDZIC R, Marjanski T, Binczyk F, Polanska J, et al
   Favourable outcomes in patients with early-stage non-small-cell lung cancer operated on by video-assisted thoracoscopic surgery: a propensity score-matched analysis.
   Eur J Cardiothorac Surg. 2018 Mar 14. pii: 4934946. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
4. VON MEYENFELDT EM, Marres GMH, van Thiel E, Damhuis RAM, et al
   Variation in length of hospital stay after lung cancer surgery in the Netherlands.
   Eur J Cardiothorac Surg. 2018 Mar 5. pii: 4921284. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   February 2018
5. CHO S, Yum S, Kim K, Jheon S, et al
   Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer.
   Eur J Cardiothorac Surg. 2018 Feb 27. pii: 4912385. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
6. DECALUWE H, Moons J, Fieuws S, De Wever W, et al
   Is central lung tumour location really predictive for occult mediastinal nodal disease in (suspected) non-small-cell lung cancer staged cN0 on 18F-fluorodeoxyglucose positron emission tomography-computed tomography?
   Eur J Cardiothorac Surg. 2018 Feb 13. pii: 4855994. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
7. WANG G, Ma W, Li Y, Jiang Y, et al
   Prognostic value of Twist, Snail and E-cadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study.
   Eur J Cardiothorac Surg. 2018 Feb 5. pii: 4838788. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
8. HONG TH, Cho JH, Shin S, Kim HK, et al
   Extended sleeve lobectomy for centrally located non-small-cell lung cancer: a 20-year single-centre experience.
   Eur J Cardiothorac Surg. 2018 Feb 2. pii: 4835395. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   January 2018
9. ARMANI G, Madeddu D, Mazzaschi G, Bocchialini G, et al
   Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
   Eur J Cardiothorac Surg. 2018 Jan 15. pii: 4810371. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
   
10. GUNN J, Valo J, Sipila J, Rautava P, et al
    Trends and results of lung cancer surgery in Finland between 2004 and 2014.
    Eur J Cardiothorac Surg. 2018 Jan 8. pii: 4793386. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2017
11. XIE D, Allen MS, Marks R, Jiang G, et al
    Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.
    Eur J Cardiothorac Surg. 2017 Dec 27. pii: 4780277. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
12. TAMBURINI N, Maniscalco P, Mazzara S, Maietti E, et al
    Multidisciplinary management improves survival at 1 year after surgical treatment for non-small-cell lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Dec 25. pii: 4774618. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
13. WEDER W, Moghanaki D, Stiles B, Siva S, et al
    The great debate flashes: Surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 21. pii: 4772266. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
14. HINO H, Karasaki T, Yoshida Y, Fukami T, et al
    Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years.
    Eur J Cardiothorac Surg. 2017 Dec 18. pii: 4759172. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
15. YENDAMURI S, Groman A, Miller A, Demmy T, et al
    Risk and benefit of neoadjuvant therapy among patients undergoing resection for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 13. pii: 4740938. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
16. SAJI H, Ueno T, Nakamura H, Okumura N, et al
    A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303.
    Eur J Cardiothorac Surg. 2017 Dec 11. pii: 4731648. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
17. SAGAWA M, Oizumi H, Suzuki H, Uramoto H, et al
    A prospective 5-year follow-up study after limited resection for lung cancer with ground-glass opacity.
    Eur J Cardiothorac Surg. 2017 Dec 9. pii: 4718127. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
18. TAKIZAWA H, Kondo K, Kawakita N, Tsuboi M, et al
    Autofluorescence for the diagnosis of visceral pleural invasion in non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Dec 8. pii: 4710341. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    November 2017
19. STILES BM, Rahouma M, Hussein MK, Nasar A, et al
    Never smokers with resected lung cancer: different demographics, similar survival.
    Eur J Cardiothorac Surg. 2017 Nov 22. pii: 4652925. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
20. SAWABATA N
    Pulmonary wedge resection for Stage I non-small-cell lung cancer: possible alternative strategy to lobectomy.
    Eur J Cardiothorac Surg. 2017 Nov 3. doi: 10.1093.
    PubMed     Text format    
    
    
    October 2017
21. DE WOLF J, Bellier J, Lepimpec-Barthes F, Tronc F, et al
    Exhaustive preoperative staging increases survival in resected adrenal oligometastatic non-small-cell lung cancer: a multicentre study.
    Eur J Cardiothorac Surg. 2017;52:698-703.
    PubMed     Text format     Abstract available
    
    
    September 2017
22. GU C, Pan X, Chen Y, Yang J, et al
    Short-term and mid-term survival in bronchial sleeve resection by robotic system versus thoracotomy for centrally located lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
23. DECALUWE H, Petersen RH, Brunelli A, Pompili C, et al
    Multicentric evaluation of the impact of central tumour location when comparing rates of N1 upstaging in patients undergoing video-assisted and open surgery for clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 27. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
24. TSUTANI Y, Tsubokawa N, Ito M, Misumi K, et al
    Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical Stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Sep 6. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    August 2017
25. YANG S, Guo W, Chen X, Wu H, et al
    Early outcomes of robotic versus uniportal video-assisted thoracic surgery for lung cancer: a propensity score-matched study.
    Eur J Cardiothorac Surg. 2017 Aug 30. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
26. ABAH U, Casali G, Batchelor TJP, Internullo E, et al
    Pathological lymph node involvement is not a predictor of adverse outcomes in patients undergoing thoracoscopic lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Aug 29. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
27. UDA K, Matsui H, Fushimi K, Yasunaga H, et al
    Preoperative short-term plus postoperative physical therapy versus postoperative physical therapy alone for patients undergoing lung cancer surgery: retrospective analysis of a nationwide inpatient database.
    Eur J Cardiothorac Surg. 2017 Aug 18. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    July 2017
28. ZEHNDER A, Kocher GJ, Seitz M, Schmid RA, et al
    IgG4-related disease of the lung: a rare differential diagnosis to lung cancer after positive positron emission tomography and biopsy.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
29. BUGGE AS, Lund MB, Valberg M, Brustugun OT, et al
    Cause-specific death after surgical resection for early-stage non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017 Jul 25. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
30. GUIRAO MONTES A, Molins Lopez-Rodo L, Ramon Rodriguez I, Sunyer Dequigiovanni G, et al
    Lung cancer diagnosis by trained dogs.
    Eur J Cardiothorac Surg. 2017 Jul 24. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
31. ENDO S, Ikeda N, Kondo T, Nakajima J, et al
    Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014-2015.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
32. PERIKLEOUS P, Bilancia R, Oey I, Waller DA, et al
    Hybrid bilobectomy for treatment of an early-stage lung cancer in a patient with severe emphysema using the benefits of lung volume reduction.
    Eur J Cardiothorac Surg. 2017 Jul 21. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
33. YANG CC, Fong Y, Lin LC, Que J, et al
    The age-adjusted Charlson comorbidity index is a better predictor of survival in operated lung cancer patients than the Charlson and Elixhauser comorbidity indices.
    Eur J Cardiothorac Surg. 2017 Jul 4. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    June 2017
34. CAGINI L, Balloni S, Ludovini V, Andolfi M, et al
    Variations in gene expression of lung macromolecules after induction chemotherapy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Jun 19. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    May 2017
35. SEKIHARA K, Hishida T, Yoshida J, Oki T, et al
    Long-term survival outcome after postoperative recurrence of non-small-cell lung cancer: who is 'cured' from postoperative recurrence?
    Eur J Cardiothorac Surg. 2017 May 8. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
36. NAKAJIMA J, Iida T, Okumura S, Horio H, et al
    Recent improvement of survival prognosis after pulmonary metastasectomy and advanced chemotherapy for patients with colorectal cancer.
    Eur J Cardiothorac Surg. 2017;51:869-873.
    PubMed     Text format     Abstract available
    
    
    
37. NOVOA NM, Esteban P, Rodriguez M, Gomez MT, et al
    Functional evaluation before lung resection: searching for a low technology test in a safer environment for the patient: a pilot study.
    Eur J Cardiothorac Surg. 2017;51:856-860.
    PubMed     Text format     Abstract available
    
    
    
38. CATTONI M, Vallieres E, Brown LM, Sarkeshik AA, et al
    Is there a role for traditional nuclear medicine imaging in the management of pulmonary carcinoid tumours?
    Eur J Cardiothorac Surg. 2017;51:874-879.
    PubMed     Text format     Abstract available
    
    
    
39. SATO M, Kuwata T, Yamanashi K, Kitamura A, et al
    Safety and reproducibility of virtual-assisted lung mapping: a multicentre study in Japan.
    Eur J Cardiothorac Surg. 2017;51:861-868.
    PubMed     Text format     Abstract available
    
    
    April 2017
40. FILOSSO PL, Guerrera F, Evangelista A, Galassi C, et al
    Adjuvant chemotherapy for large-cell neuroendocrine lung carcinoma: results from the European Society for Thoracic Surgeons Lung Neuroendocrine Tumours Retrospective Database.
    Eur J Cardiothorac Surg. 2017 Apr 28. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
41. BENDIXEN M, Licht PB
    Video-assisted thoracoscopic surgery versus open lobectomy for lung cancer: time for a randomized trialdagger.
    Eur J Cardiothorac Surg. 2017 Apr 27. doi: 10.1093.
    PubMed     Text format    
    
    
    
42. KARENOVICS W, Licker M, Ellenberger C, Christodoulou M, et al
    Short-term preoperative exercise therapy does not improve long-term outcome after lung cancer surgery: a randomized controlled studydagger.
    Eur J Cardiothorac Surg. 2017 Apr 17. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
43. WELTER S, Arfanis E, Christoph D, Hager T, et al
    Growth patterns of pulmonary metastases: should we adjust resection techniques to primary histology and size?dagger.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
44. DZIEDZIC R, Zurek W, Marjanski T, Rudzinski P, et al
    Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registrydagger.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
45. ANDERSON KL JR, Mulvihill MS, Yerokun BA, Speicher PJ, et al
    Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.
    Eur J Cardiothorac Surg. 2017 Apr 11. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    March 2017
46. SCHIRREN J, Schirren M, Lampl L, Sponholz S, et al
    Surgery for pulmonary metastases: quo vadis?
    Eur J Cardiothorac Surg. 2017;51:408-410.
    PubMed     Text format    
    
    
    February 2017
47. BILLE A, Woo KM, Ahmad U, Rizk NP, et al
    Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Eur J Cardiothorac Surg. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    
    
    
    
48. SZANTO Z, Benko I, Jakab L, Szalai G, et al
    The use of a smartphone application for fast lung cancer risk assessmentdagger.
    Eur J Cardiothorac Surg. 2017 Feb 10. doi: 10.1093.
    PubMed     Text format    
    
    
    
49. DENG HY, Wang YC, Ni PZ, Li G, et al
    Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2017;51:203-210.
    PubMed     Text format    
    
    
    January 2017
50. PEDERSEN JH, Rzyman W, Veronesi G, D'Amico TA, et al
    Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.
    Eur J Cardiothorac Surg. 2017 Jan 30. pii: ezw418. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
51. MOKHLES S, Macbeth F, Treasure T, Younes RN, et al
    Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis.
    Eur J Cardiothorac Surg. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format    
    
    
    
52. MATSUNAGA T, Suzuki K, Takamochi K, Oh S, et al
    What is the radiological definition of part-solid tumour in lung cancer?dagger.
    Eur J Cardiothorac Surg. 2017 Jan 24. pii: ezw344. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
53. POMPILI C, Velikova G, White J, Callister M, et al
    Poor preoperative patient-reported quality of life is associated with complications following pulmonary lobectomy for lung cancer.
    Eur J Cardiothorac Surg. 2017 Jan 12. pii: ezw363. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    December 2016
54. LI S, Wang Z, Huang J, Fan J, et al
    Systematic review of prognostic roles of body mass index for patients undergoing lung cancer surgery: does the 'obesity paradox' really exist?
    Eur J Cardiothorac Surg. 2016 Dec 30. pii: ezw386. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    
55. GUERRERA F, Renaud S, Tabbo F, Voegeli' AC, et al
    Epidermal growth factor receptor mutations are linked to skip N2 lymph node metastasis in resected non-small-cell lung cancer adenocarcinomasdagger.
    Eur J Cardiothorac Surg. 2016 Dec 15. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
    October 2016
56. SHIONO S, Okumura T, Boku N, Hishida T, et al
    Outcomes of segmentectomy and wedge resection for pulmonary metastases from colorectal cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    September 2016
57. DENG HY, Wang YC, Ni PZ, Li G, et al
    Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    July 2016
58. LEE GD, Kim DK, Jang SJ, Choi SH, et al
    Significance of R1-resection at the bronchial margin after surgery for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
59. RIQUET M, Arame A, Pricopi C, Foucault C, et al
    Visceral pleura and pN involvement in lung cancer.
    Eur J Cardiothorac Surg. 2016;50:193.
    PubMed     Text format    
    
    
    
60. HOFFERBERTH SC, Grinstaff MW, Colson YL
    Nanotechnology applications in thoracic surgery.
    Eur J Cardiothorac Surg. 2016;50:6-16.
    PubMed     Text format     Abstract available
    
    
    
61. DECALUWE H, Stanzi A, Dooms C, Fieuws S, et al
    Central tumour location should be considered when comparing N1 upstaging between thoracoscopic and open surgery for clinical stage I non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;50:110-7.
    PubMed     Text format     Abstract available
    
    
    
62. STAMENOVIC D, Bostanci K, Messerschmidt A, Jahn T, et al
    Fissureless fissure-last video-assisted thoracoscopic lobectomy for all lung lobes: a better alternative to decrease the incidence of prolonged air leak?
    Eur J Cardiothorac Surg. 2016;50:118-23.
    PubMed     Text format     Abstract available
    
    
    
63. CHIAPPETTA M, Nachira D, Margaritora S, Granone P, et al
    Are digital devices routinely useful in thoracic surgery or are they helpful only in selected cases?
    Eur J Cardiothorac Surg. 2016;50:192.
    PubMed     Text format    
    
    
    June 2016
64. PIRRO M, Cagini L, Mannarino MR, Andolfi M, et al
    Reduced survival in patients with early-stage non-small-cell lung cancer is associated with high pleural endothelial progenitor cell levels.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
65. KIRCHEVA DY, Husain AN, Watson S, Kindler HL, et al
    Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
    Eur J Cardiothorac Surg. 2016;49:1642-7.
    PubMed     Text format     Abstract available
    
    
    
66. WATANABE K, Tsuboi M, Sakamaki K, Nishii T, et al
    Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016;49:1624-31.
    PubMed     Text format     Abstract available
    
    
    
67. WALLER DA
    The staging of malignant pleural mesothelioma: are we any nearer to squaring the circle?
    Eur J Cardiothorac Surg. 2016;49:1648-9.
    PubMed     Text format    
    
    
    May 2016
68. RIQUET M, Legras A, Pricopi C, Le-Pimpec-Barthes F, et al
    Microscopic pN2 in lung cancer: a better prognosis?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    
    
    
    
69. LIU J, Cui F, Pompeo E, Gonzalez-Rivas D, et al
    The impact of non-intubated versus intubated anaesthesia on early outcomes of video-assisted thoracoscopic anatomical resection in non-small-cell lung cancer: a propensity score matching analysis.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
70. SWANSON SJ
    The value of video-assisted thoracoscopic surgery: follow the money!
    Eur J Cardiothorac Surg. 2016;49:1496.
    PubMed     Text format    
    
    
    April 2016
71. BOLUKBAS S, Eberlein M
    Biomarker-driven early lung cancer therapy: the future is now?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    
    
    
    
72. LIN JT, Yang XN, Zhong WZ, Liao RQ, et al
    Association of maximum standardized uptake value with occult mediastinal lymph node metastases in cN0 non-small cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
73. MENG D, Zhou Z, Wang Y, Wang L, et al
    Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
74. BRUNELLI A
    Ventilatory efficiency slope: an additional prognosticator after lung cancer surgery.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    
    
    
    
75. SHAFIEK H, Valera JL, Togores B, Torrecilla JA, et al
    Risk of postoperative complications in chronic obstructive lung diseases patients considered fit for lung cancer surgery: beyond oxygen consumption.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
76. ROCCO G, Nason K, Brunelli A, Varela G, et al
    Management of stage IIIA (N2) non-small-cell lung cancer: a transatlantic perspectivedagger.
    Eur J Cardiothorac Surg. 2016;49:1025-7.
    PubMed     Text format    
    
    
    March 2016
77. DZIEDZIC D, Rudzinski P, Langfort R, Orlowski T, et al
    Results of surgical treatment and impact on T staging of non-small-cell lung cancer adjacent lobe invasion.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
78. WOOD DE
    Re: Lung cancer screening: did we really need a randomized controlled trial?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format    
    
    
    
79. AL-AYOUBI AM, Flores RM
    Lung cancer screening: did we really need a randomized controlled trial?
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
80. FUKUI M, Takamochi K, Matsunaga T, Oh S, et al
    Risk of the preoperative underestimation of tumour size of lung cancer in patients with idiopathic interstitial pneumoniasdagger.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    February 2016
81. GARELLI E, Renaud S, Falcoz PE, Weingertner N, et al
    Microscopic N2 disease exhibits a better prognosis in resected non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
82. THOMAS PA, Falcoz PE, Bernard A, Le Pimpec-Barthes F, et al
    Bilobectomy for lung cancer: contemporary national early morbidity and mortality outcomes.
    Eur J Cardiothorac Surg. 2016;49:e38-43.
    PubMed     Text format     Abstract available
    
    
    January 2016
83. NAGAYASU T, Sato S, Yamamoto H, Yamasaki N, et al
    The impact of certification of general thoracic surgeons on lung cancer mortality: a survey by The Japanese Association for Thoracic Surgerydagger.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
84. EDWARDS JP, Datta I, Hunt JD, Stefan K, et al
    Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforcedagger.
    Eur J Cardiothorac Surg. 2016.
    PubMed     Text format     Abstract available
    
    
    
85. XIE D, Wang H, Fei K, Chen C, et al
    Single-port video-assisted thoracic surgery in 1063 cases: a single-institution experiencedagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i31-6.
    PubMed     Text format     Abstract available
    
    
    
86. GONZALEZ-RIVAS D, Yang Y, Stupnik T, Sekhniaidze D, et al
    Uniportal video-assisted thoracoscopic bronchovascular, tracheal and carinal sleeve resectionsdagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i6-16.
    PubMed     Text format     Abstract available
    
    
    
87. NG CS, Yu SC, Lau RW, Yim AP, et al
    Hybrid DynaCT-guided electromagnetic navigational bronchoscopic biopsydagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i87-8.
    PubMed     Text format     Abstract available
    
    
    
88. HIRAI K, Takeuchi S, Usuda J
    Single-incision thoracoscopic surgery and conventional video-assisted thoracoscopic surgery: a retrospective comparative study of perioperative clinical outcomesdagger.
    Eur J Cardiothorac Surg. 2016;49 Suppl 1:i37-41.
    PubMed     Text format     Abstract available
    
    
    December 2015
89. VAN SCHIL PE
    Stage IIIA-N2 non-small-cell lung cancer: from 'surprise' involvement to surgical nightmare.
    Eur J Cardiothorac Surg. 2015.
    PubMed     Text format    
    
    
    May 2015
90. MARJANSKI T, Wnuk D, Bosakowski D, Szmuda T, et al
    Patients who do not reach a distance of 500 m during the 6-min walk test have an increased risk of postoperative complications and prolonged hospital stay after lobectomy.
    Eur J Cardiothorac Surg. 2015;47:e213-9.
    PubMed     Text format     Abstract available
    
    
    
91. JIMENEZ MF
    Uniportal versus standard video-assisted thoracoscopic surgery for lung lobectomy: changing the standards requires scientific evidence.
    Eur J Cardiothorac Surg. 2015;47:916.
    PubMed     Text format    
    
    
    March 2015
92. TAKENAKA T, Takenoyama M, Yamaguchi M, Toyozawa R, et al
    Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2015;47:550-5.
    PubMed     Text format     Abstract available
    
    
    
93. RIED M, Lehle K, Neu R, Diez C, et al
    Assessment of cisplatin concentration and depth of penetration in human lung tissue after hyperthermic exposure.
    Eur J Cardiothorac Surg. 2015;47:563-6.
    PubMed     Text format     Abstract available
    
    
    
94. JEON JH, Kang CH, Kim HS, Seong YW, et al
    Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.
    Eur J Cardiothorac Surg. 2015;47:556-62.
    PubMed     Text format     Abstract available
    
    
    January 2015
95. OBESO CARILLO GA, Casais Pampin R, Legarra Calderon JJ, Pradas Montilla G, et al
    Primary pulmonary artery sarcoma: a new surgical technique for pulmonary artery reconstruction using a self-made stapled bovine pericardial graft conduit.
    Eur J Cardiothorac Surg. 2015;47:188-90.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: